MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 189 filers reported holding MYRIAD GENETICS INC in Q4 2020. The put-call ratio across all filers is 0.81 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SCOPIA CAPITAL MANAGEMENT LP | 5,809,799 | $205,667,000 | 4.45% |
| Tieton Capital Management, LLC | 146,650 | $5,191,000 | 3.90% |
| KESTREL INVESTMENT MANAGEMENT CORP | 614,275 | $21,745,000 | 2.97% |
| Provident Investment Management, Inc. | 375,032 | $13,276,000 | 2.70% |
| Summit Street Capital Management, LLC | 77,810 | $2,754,000 | 2.46% |
| RATIONAL ADVISORS LLC | 253,200 | $8,963,000 | 2.17% |
| S&T BANK/PA | 393,446 | $13,928,000 | 2.08% |
| Euclidean Technologies Management, LLC | 63,684 | $2,254,000 | 2.05% |
| Grace Capital | 220,769 | $7,815,000 | 1.76% |
| AIMZ Investment Advisors, LLC | 57,850 | $2,048,000 | 1.75% |